Bromadol BDPC, the recently synthetic opioid, has unique biological qualities. This compound mainly works as an partial μ-opioid binding site stimulant, however demonstrates considerable activity at the κ-opioid location as also. This dual effect results at a intricate set regarding consequences, such as pain reduction, drowsiness, plus possib